These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 3741469)

  • 1. In vitro studies on the metabolism and covalent binding of [14C]1,1-dichloroethylene by mouse liver, kidney and lung.
    Okine LK; Gram TE
    Biochem Pharmacol; 1986 Aug; 35(16):2789-95. PubMed ID: 3741469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic activation of 1,1-dichloroethylene by mouse lung and liver microsomes.
    Forkert PG; Hofley M; Racz WJ
    Can J Physiol Pharmacol; 1987 Jul; 65(7):1496-9. PubMed ID: 3664363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the distribution and covalent binding of 1,1-dichloroethylene in the mouse. Effect of various pretreatments on covalent binding in vivo.
    Okine LK; Goochee JM; Gram TE
    Biochem Pharmacol; 1985 Nov; 34(22):4051-7. PubMed ID: 4062975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of isozymes of cytochrome P-450 in the metabolism of N,N-dimethyl-4-aminoazobenzene in the rat.
    Levine WG; Lu AY
    Drug Metab Dispos; 1982; 10(2):102-9. PubMed ID: 6124393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of covalent binding of [14C]-2-chloro-4-acetotoluidide to microsomes of starling liver and kidney.
    Giri SN; Siegel DM
    J Biochem Toxicol; 1991; 6(2):137-45. PubMed ID: 1941900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of administration of metabolic inducers and inhibitors on pulmonary toxicity and covalent binding by 1,1-dichloroethylene in CD-1 mice.
    Forkert PG; Stringer V; Racz WJ
    Exp Mol Pathol; 1986 Aug; 45(1):44-58. PubMed ID: 3758307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cytochrome P450 inducers on I-compounds in rat liver and kidney DNA.
    Li D; Moorthy B; Chen S; Randerath K
    Carcinogenesis; 1992 Jul; 13(7):1191-8. PubMed ID: 1638686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hyperthyroidism on the in vitro metabolism and covalent binding of 1,1-dichloroethylene in rat liver microsomes.
    Gunasena GH; Kanz MF
    J Toxicol Environ Health; 1997 Oct; 52(2):169-88. PubMed ID: 9310148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism for isaxonine hepatitis. I. Metabolic activation by mouse and human cytochrome P-450.
    Lettéron P; Fouin-Fortunet H; Tinel M; Danan G; Belghiti J; Pessayre D
    J Pharmacol Exp Ther; 1984 Jun; 229(3):845-50. PubMed ID: 6547179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 1,2-dichloroethylenes: their metabolism by hepatic cytochrome p-450 in vitro.
    Costa AK; Ivanetich KM
    Biochem Pharmacol; 1982 Jun; 31(11):2093-102. PubMed ID: 7115427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of the "mixed" cytochrome P-450 inducer hexachlorobenzene by rat liver microsomes.
    Stewart FP; Smith AG
    Biochem Pharmacol; 1986 Jul; 35(13):2163-70. PubMed ID: 3729973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic and pulmonary microsomal metabolism of naphthalene to glutathione adducts: factors affecting the relative rates of conjugate formation.
    Buckpitt AR; Bahnson LS; Franklin RB
    J Pharmacol Exp Ther; 1984 Nov; 231(2):291-300. PubMed ID: 6491983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of 8-methoxypsoralen by cytochrome P-450. Enzyme kinetics of covalent binding and influence of inhibitors and inducers of drug metabolism.
    Mays DC; Hilliard JB; Wong DD; Gerber N
    Biochem Pharmacol; 1989 May; 38(10):1647-55. PubMed ID: 2730678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic microsomal metabolism of the dichloroethanes.
    McCall SN; Jurgens P; Ivanetich KM
    Biochem Pharmacol; 1983 Jan; 32(2):207-13. PubMed ID: 6870950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioactivation of 8-methoxypsoralen and irreversible inactivation of cytochrome P-450 in mouse liver microsomes: modification by monoclonal antibodies, inhibition of drug metabolism and distribution of covalent adducts.
    Mays DC; Hilliard JB; Wong DD; Chambers MA; Park SS; Gelboin HV; Gerber N
    J Pharmacol Exp Ther; 1990 Aug; 254(2):720-31. PubMed ID: 2117068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for hepatic formation, export and covalent binding of reactive naphthalene metabolites in extrahepatic tissues in vivo.
    Buckpitt AR; Warren DL
    J Pharmacol Exp Ther; 1983 Apr; 225(1):8-16. PubMed ID: 6834280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of cytochrome P4503A in catalysis of tamoxifen activation and covalent binding to rat and human liver microsomes.
    Mani C; Pearce R; Parkinson A; Kupfer D
    Carcinogenesis; 1994 Dec; 15(12):2715-20. PubMed ID: 8001226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of rat liver microsomal cytochrome P-450 during methimazole metabolism. Role of flavin-containing monooxygenase.
    Kedderis GL; Rickert DE
    Drug Metab Dispos; 1985; 13(1):58-61. PubMed ID: 2858378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of multiple forms of mouse liver cytochrome P-450. Evidence for genetically controlled de novo protein synthesis in response to treatment with beta-naphthoflavone or phenobarbital.
    Haugen DA; Coon MJ
    J Biol Chem; 1976 Mar; 251(6):1817-27. PubMed ID: 1254598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsomal metabolism of the carcinogen, N-2-fluorenylacetamide, by the mammary gland and liver of female rats. I. Ring- and N-hydroxylations of N-2-fluorenylacetamide.
    Malejka-Giganti D; Decker RW; Ritter CL; Polovina MR
    Carcinogenesis; 1985 Jan; 6(1):95-103. PubMed ID: 3967341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.